Sales Veränderung Datum
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Capricor Therapeutics USD 12.09M 5.9M 2023-12
Daiichi Sankyo JPY 446.92B 71.42B 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Esperion Therapeutics USD 32.25M 1.72M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Insmed USD 83.69M 4.62M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Lumos Pharma USD 826K 819K 2023-12
Moderna USD 2.81B 980M 2023-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novavax USD 291.34M 104.36M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Roche Holding CHF 28.94B 842M 2023-12
Sangamo BioSciences USD 2.04M 7.36M 2023-12
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Sarepta Therapeutics Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.